FertilHom comes to the aid of men who want to improve their fertility.

Completely natural and without side effects, FertilHom makes it possible to increase the number of spermatozoa and their mobility.






Download our PowerPoint presentation by clicking here.


Approximately 15% of couples attempting their first pregnancy meet a failure. Most authorities define these patients as primarily infertile if they have been unable to achieve a pregnancy after one year of unprotected intercourse.
Conception normally is achieved within twelve months in 80-85% of couples who use no contraceptive measures, and persons presenting after this time should therefore be regarded as possibly infertile and should be evaluated.

Data available over the past twenty years reveal that in approximately 30% of cases pathology is found in the man alone, and in another 20% both the man and woman are showing reduced fertility. Therefore, the male factor is at least partly responsible in about 50% of infertile couples.


Male infertility may be various in origin. First of all we make a difference between infertility and reduced fertility. Infertility can be classified as follows:

  • Pre-testicular factors of endocrine origin due to hypothalamic and pituitary disorders. The problems of hypogonadism or the consequence of problems connected with intercourse can be given as examples (anomalies of the penis, difficulties with erection, ejaculation, etc.)
  • Tesitcular factors of genetic origin (deletion on the Y chromosome), of congenital origin (cryptorchidism), of infectious origin (viral orchitis) or even due to the action of toxic agents (chemical, physical or biological) which adversely affect the physiological control process and affect normal gonad function.
  • Post-testicular factors due either to unilateral or bilateral congenital or acquired obstruction of the genital tract, with variable consequences for fertility, or to an acute or chronic infection such as urethritis, or to an immunological cause.


In such cases remedies for infertility may be note easy or even being impossible to cure.

Reduced fertility on the other hand has different causes and will mostly reflect in decreased mobility of spermatozoids, malformations, reduced sperm count and other factors causing decrease of semen quality. Such factors may be:

Contact with toxic agents which may be gonadotoxic or antispermatogenic. There exist a lot of such substances with which we daily may have contact, professional or in our all-day life. These substances affect a significant proportion of the population.

  • Organochlorines (DDT, PCB, dioxin), used as pesticides in agriculture or even while gardening. These substances have œstrogenic effects in man and block the androgen receptors. They also induce changes in the quality of the sperm and in the size of the testicles.
  • Heavy metals used in the industry but also present in many products like batteries, paint, ink…

Tobacco and smoking causes a harmful effect on the number, mobility and morphology of the spermatozoa by adversely affecting spermatogenesis. Furthermore, cigarette smoke is the source of the creation of activated oxygenated substances (free radicals) which are also harmful to spermatozoa.
Currently there is also an increase in the consumption of socalled recreational drugs (marijuana, cocaine).

Chronic alcohol consumption causes a reduction in the count and number of normal spermatozoa. In the case of alcoholism, sexual function is also adversely affected.


Spermatozoa in a normal form
Spermatozoa in abnormal forms

Pharmacological agents affect fertility according to the dose used and the period over which they are prescribed.

  • Antimicrobials (tetracyclines and neomycins) disrupt the proper functioning of the spermatozoa and spermatogenesis.
  • The antineoplastics used in chemotherapy and the X and Y rays used in radiotherapy block spermatogenesis and cause structural anomalies in the spermatozoa.
  • Cyclosporine, used as an immunosuppressant after transplantation, has a hypoandrogenic effect.
  • Hormones. Our meat is normally hormonefree, although some practices still may occur. Hormones are stored in the adipose tissue of meat and in this way they can enter our body after consumption. Unfortunately there is still an abuse in the world of sport where hormones still are used as doping products.

Physical gonadotoxic events may affect us to a greater extent as they involve a large proportion of the male sex (for example: an increase in temperature in the scrotum). This may due to wearing tight clothes (jeans for instance) but also remaining seated for many hours (office work, bus, truck andtaxi drivers, long airplane flights etc.).

In order to determine the biological criteria which define a man’s fertility status, the WHO (World Health Organisation) has drawn up standards for analysing sperm.


Volume of sperm per ejaculation 2ml
Concentration of spermatozoa 20 millions / ml
Mobility of spermatozoa 50%
Speed of progression of spermatozoa (on a scale of 0 to 4) 3
% of spermatozoa with normal morphology (WHO value) 30%
Total number of spermatozoa 40 millions
Total number of mobile spermatozo 20 millions
Total number of functional spermatozoa 6 millions


Only the results of a spermogram can reveal whether there is hypofertility, normal fertility or even hyperfertility.

In cases of hypofertility confirmed by the spermogram, several nutrients have proved to be useful for improving the deficient parameters.
FERTILHOM offers a unique combination of these useful nutrients


Nutrient composition Daily (for 1 sachet)
L-carnitine fumarate 2900 mg
Acetyl-L-carnitine 500 mg
L-arginine 250 mg
Glutathione 100 mg
Coenzyme Q10 40 mg
Zinc 7,5 mg
Vitamin B9 200 µg
Selenium 50 µg
Vitamin B12 2 µg

Fertilhom composition provides useful nutrients in order to increase male fertility : L-carnitine fumarate, acetylL-carnitine, L-arginine, Glutathione, Coenzyme Q10, Zinc, Vitamin B9, Selenium, Vitamin B12.

FertilHom recommended use


L-carnitine fumarate and acetyl-L-carnitine are the main ingredients of FertilHom. Chemically, carnitine is related to the amino acids but is not a constituent of proteins. It serves as a transporter of fatty acids to their oxidation site so that these undergo mitochondrial 3-oxidation and thus provide the energy necessary for spermatozoid mobility.
Correlations are seen in hypofertile men between the concentration of carnitine and mobility and sperm count. A supplementation of 3 g of L-Carnitin per day for 3 to 4 months to men suffering from idiopathic asthenospermia has made it possible to increase the number of mobile spermatozoa by 10% and bring about an 8% increase in spermatozoa with rapid linear progression12-20,27,32,44-45.

Arginine is a non-essential amino acid but which is necessary for the production of high-quality sperm. The physiological production of arginine reduces with age and a supplement of arginine has proved to be effective in older men. Studies show that taking supplements for several months increases the quality and quantity of the spermatozoa8,9 and therefore fertility10,11.

Glutathione acts as an antioxidant. The glutathione enzymes peroxidase and reductase play crucial roles in combatting oxidative stress damaging the quality of the sperm. Any reduction in the levels of glutathione (GSH) during spermatogenesis is clearly linked to defects in the integrity of the membrane of the spermatozoa49-51.

Coenzyme Q10 is another liposoluble antioxidant, useful for spermatozoa morphology. Its endogenous synthesis requires the presence of vitamins C, B2, B5, B6, B9 et B12 but it reduces gradually with age after 25 years of age.
Ubiquinone is extremely concentrated in the mitochondria of the intermediate part of the spermatozoa where it has a dual function: as a powerful antioxidant AND as an intermediary of the respiratory chain. Coenzyme Q10 is therefore essential for the production of energy in the spermatozoa. It performs vital functions for the spermatozoa. Indeed their great mobility involves an enormous energy requirement. Coenzyme Q10 helps to increase the number and mobility of the spermatozoa24.


Zinc is a really essential element to the reproductive function of men. In the area of fertility, it is indispensable for testicular development, spermatogenesis, the mobility of the spermatozoa and 5-α-reductase activity (the enzyme necessary for converting testosterone into 5-α-dihydrotestosterone, a biologically active form of testosterone). A zinc deficiency as a cause of oligospermia, impotence and hypogonadism has long been known about in rodents and in man5

Apart from its well-studied function as an antioxidant, selenium plays a role in the biosynthesis of testosterone and in the formation and development of the spermatozoa.
A group of researchers has moreover identified a keratinoid selenium protein called GPX4: this structural protein is associated with the mitochondrial capsule of the spermatozoa. It makes up 50% of this capsule and thus provides the integrity required by the flagellum to ensure its mobility and stability.
Unlike the other glutathione peroxidases, GPX4 does not have any direct antioxidant action at this level. Other glutathione peroxidases take care of this. It plays a role in the structure formation and thus does not act as a catalyser of reaction25.

Several studies have reported that in men with fertility problems, their vitamin B9 and B12 statuses were deficient.1-3,17,18


Indeed, any vitamin B12 deficiency is correlated with a loss of mobility and a reduced number of spermatozoa. Also, when folic acid (vitamin B9) is administered together with zinc to hypofertile men, their sperm quality is significantly better compared with administration of either vitamin B9 or zinc alone.22,46


  • 1. Werbach MR. Nutritional Influences on Illness: A Sourcebook of Clinical Research. 2nd ed. Tarzana, CA: Third Line Press; 1993:628629.
  • 2. Saltzman JR, Kemp JA, Golner BB, et al. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. J Am Coll Nutr. 1994;13:584-591.
  • 3. Kumamoto Y, Maruta H, Ishigami J, et al. Clinical efficacy of mecobalamin in treatment of oligozoospermia: results of doubleblind comparative clinical study [in Japanese; English abstract]. Hinyokika Kiyo. 1988;34:1109-1132.
  • 4. Bedwal RS, Bahuguna A. Zinc, copper and selenium in reproduction. Experientia. 1994;50:626-640.
  • 5. Netter A, Hartoma R, Nahoul K. Effect of zinc administration on plasma testosterone, dihydrotestosterone, and sperm count. Arch Androl. 1981;7:69-73.
  • 6. Suleiman SA, Elamin Ali M, Zaki ZMS, et al. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl. 1996;17:530-537.
  • 7. Dawson EB, Harris WA, Rankin WE, et al. Effect of ascorbic acid on male fertility. Ann N Y Acad Sci. 1987;498:312-323.
  • 8. Rolf C, Cooper TG, Yeung CH, et al. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebocontrolled, double-blind study. Hum Reprod. 1999;14:1028-1033.
  • 9. Conquer JA, Martin JB, Tummon I, et al. Effect of DHA supplementation on DHA status and sperm motility in asthenozoospermic males. Lipids. 2000;35:149-154.
  • 10. Armanini D, Palermo M. Reduction of serum testosterone in men by licorice. N Engl J Med. 1999;341:1158.
  • 11. Salvati G, Genovesi G, Marcellini L, et al. Effects of Panax ginseng C.A. Meyer saponins on male fertility. Panminerva Med. 1996;38:249-254.
  • 12. Loumbakis P, Anezinis P, Evangeliou A, et al. Effect of L-carnitine in patients with asthenospermia [abstract]. Eur Urol. 1996;30(suppl 2):255.
  • 13. Muller-Tyl E, Lohninger A, Fischl F, et al. The effect of carnitine on sperm count and sperm motility [translated from German]. Fertilitat. 1988;4:1-4.
  • 14. Micic S, Lalic N, Nale DJ, et al. Effects of L-carnitine on sperm motility and number in infertile men [abstract]. Fertil Steril. 1998;70(3 suppl 1):S12.
  • 15. Vicari E. Effectiveness of a short-term anti-oxidative high-dose therapy on IVF program outcome in infertile male patients with previous excessive sperm Radical Oxygen Species production Infertility and Assisted Reproductive Technology; June 11-14, 1997; Porto Cervo, Italy.
  • 16. Vicari E, Cerri L, Cataldo T, et al. Effectiveness of single and combined antioxidant therapy in patients with asthenonecrozoospermia from non-bacterial epididymitis: effects after acetyl-carnitine or carnitine-acetyl-carnitine. Presented at: 12th National Conference, Italian Andrology Association; June 9-12, 1999; Copanello, Italy.
  • 17. Campaniello E, Petrarolo N, Meriggiola MC, et al. Carnitine administration in asthenospermia. Presented at: 4th International Congress of Andrology; May 14-18, 1989; Florence, Italy.
  • 18. Costa M, Canale D, Filicori M, et al. L-carnitine in idiopathic asthenozoospermia: a multicenter study. Andrologia. 1994;26:155159.
  • 19. Vitali G, Parente R, Melotti C. Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res. 1995;21:157-159.
  • 20. Moncada ML, Vicari E, Cimino C, et al. Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil. 1992;23:221-224.
  • 21. Kumar R, Gupta NP. Lycopene therapy in idiopathic male infertility: results of a clinical trial [abstract]. Presented at: 34th Annual Conference of the Urological Society of India; January 1821, 2001; Nagpur, India.
  • 22. Wong WY, Merkus HM, Thomas CM, et al. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril. 2002;77:491498.
  • 23. Luboshitzky R, Shen-Orr Z, Nave R, et al. Melatonin administration alters semen quality in healthy men. J Androl. 2002;23:572-578.
  • 24. Lewin A, Lavon H. The effect of coenzyme Q10 on sperm motility and function. Mol Aspects Med. 1997;18(suppl):S213-S219.
  • 25. Scott R , MacPherson A, Yates RWS, et al. The effect of oral selenium supplementation on human sperm motility. Br J Urol. 1998;82:76-80.
  • 26. Pryor JP, Blandy JP, Evans P, et al. Controlled clinical trial of arginine for infertile men with oligozoospermia. Br J Urol. 1978;50:47-50.
  • 27. Lenzi A, Lombardo F, Sgro P, et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril. 2003;79:292-300.
  • 28. Gonzales GF, Cordova A, Vega K. Effect of Lepidium meyenii (Maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men. J Endocrinol. 2003;176:163-168.
  • 29. Gardner-Thorpe D, O’Hagen C, Young I, et al. Dietary supplements of soya flour lower serum testosterone concentrations and improve markers of oxidative stress in men. Eur J Clin Nutr. 2003;57:100-106.
  • 30. Akbarsha MA, Manivannan B, Shahul Hamid K, et al. Antifertility effect of Andrographis paniculata (Nees) in male albino rat. Indian J Exp Biol. 1990;28:421-426.
  • 31. Burgos RA, Caballero EE, Sanchez NS, et al. Testicular toxicity assessment of Andrographis paniculata dried extract in rats. J Ethnopharmacol. 1997;58:219-224.
  • 32. Lenzi A, Sgro P, Salacone P, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004;81:1578-1584.
  • 33. Cavallini G, Ferraretti AP, Gianaroli L, et al. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl. 2004;25:761-770; discussion 771-772.
  • 34. Lenzi A, Sgro P, Salacone P, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004;81:1578-1584.
  • 35. Cavallini G, Ferraretti AP, Gianaroli L, et al. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl. 2004;25:761-770; discussion 771-772.
  • 36. Lenzi A, Lombardo F, Sgro P, et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril. 2003;79:292-300.
  • 37. Comhaire FH, El Garem Y, Mahmoud A, et al. Combined conventional/antioxidant “Astaxanthin” treatment for male infertility: a double blind, randomized trial. Asian J Androl. 2005;7:257-262.
  • 38. Gonzales GF, Cordova A, Gonzales C, et al. Lepidium meyenii (Maca) improved semen parameters in adult men. Asian J Androl. 2002;3:301-303.
  • 39. Zavaczki Z, Szollosi J, Kiss SA, et al. Magnesium-orotate supplementation for idiopathic infertile male patients: a randomized, placebo-controlled clinical pilot study. Magnes Res. 2003;16:131-136.
  • 40. Akdogan M, Ozguner M, Kocak A, et al. Effects of peppermint teas on plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels and testicular tissue in rats. Urology. 2004;64:394-398.
  • 41. Melis MS. Effects of chronic administration of Stevia rebaudiana on fertility in rats. J Ethnopharm. 1999;167;157-161.
  • 42. Oliveira-Filho RM, Uehara OA, Minetti CA, et al. Chronic administration of aqueous extract of Steviarebaudiana (Bert.) Bertoni in rats: endocrine effects. Gen Pharmacol. 1989;20:187-191.
  • 43. Yodyingyuad V, Bunyawong S. Effect of stevioside on growth and reproduction. Hum Reprod. 1991;6:158-165.
  • 44. Garolla A, Maiorino M, Roverato A, et al. Oral carnitine supplementation increases sperm motility in asthenozoospermic men with normal sperm phospholipid hydroperoxide glutathione peroxidase levels. Fertil Steril. 2005;83:355-361.
  • 45. Balercia G, Regoli F, Armeni T, et al. Placebo-controlled doubleblind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril. 2005;84:662-671.
  • 46. Ebisch IM, Pierik FH, DE Jong FH, et al. Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl. 2006;29:339-345.
  • 47. Zhou X, Liu F, Zhai S. Effect of L-carnitine and/or L-acetylcarnitine in nutrition treatment for male infertility: a systematic review. Asia Pac J Clin Nutr. 2007;16(suppl):383-390.
  • 48. Reul B., Consultation préconceptionnelle et optimisation de la fécondité masculine et féminine. Sciences des Aliments, 22 (2002) 685-697.
  • 49. Irvine DS Glutathione as a treatment for male infertility. Rev Reprod. 1996 Jan;1(1):6-12.
  • 50. Sheweita SA1, Tilmisany AM, Al-Sawaf H., Mechanisms of male infertility: role of antioxidants. Curr Drug Metab. 2005 Oct;6(5):495501.
  • 51.Sikka SC., Oxidative stress and role of antioxidants in normal and abnormal sperm function. Front Biosci. 1996 Aug 1;1:e78-86.
  • 52. Wankhede S, Mohan V, Thakurdesai P, Beneficial effects of fenugreek glycoside supplementation in male subjects during resistance training: a randomized controlled pilot study, Journal of Sport and Health Science (2015), doi: 10.1016/j.jshs.2014.09.005.